Health Canada has approved a second drug that can slow the progression of Alzheimer’s disease. Donanemab, sold by American drugmaker Eli Lilly under the brand...
Descrease article font size Increase article font size The second generic version of semaglutide — the medication in brand-name drugs like Ozempic, Wegovy and Mounjaro...
